Ibuprofeno Kabi

Ibuprofen, the active ingredient in Ibuprofeno Kabi, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an intravenous formulation for injection use. It is employed to relieve pain, reduce fever, and diminish inflammation in adult patients requiring rapid therapeutic effect, such as after surgery or with acute musculoskeletal conditions. It is indicated for short‑term management of moderate to severe pain where oral administration is not feasible.

GNH USA supplies Ibuprofeno Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement teams worldwide, with a focus on quality assurance and regulatory compliance.

Ibuprofeno Kabi, an intravenous NSAID, acts on inflammatory pathways to provide analgesic, antipyretic, and anti‑inflammatory effects.

- Pain: Provides rapid relief of moderate to severe acute pain, especially postoperative or trauma‑related discomfort. - Fever: Reduces elevated body temperature by inhibiting prostaglandin synthesis in the hypothalamus. - Inflammation: Decreases swelling and tissue inflammation in musculoskeletal conditions. - Post‑operative pain: Offers short‑term control of pain after surgical procedures when oral intake is limited. - Musculoskeletal pain: Alleviates pain associated with strains, sprains, and arthritis flares.

Adverse reactions to Ibuprofeno Kabi can vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Headache: transient headache during treatment. - Dizziness: occasional light‑headedness. - Injection site pain: discomfort at the infusion site.

Serious or Rare Side Effects: - Gastrointestinal bleeding: severe bleeding in the stomach or intestines. - Renal impairment: acute kidney injury or reduced renal function. - Severe hypersensitivity: anaphylaxis, skin rash, or angio‑edema.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications. - Renal function: assess baseline renal status and monitor during therapy. - Bleeding risk: avoid in patients with active gastrointestinal ulcer or coagulopathy. - Cardiovascular health: use cautiously in patients with hypertension or heart failure. - Pregnancy: consider risk/benefit; generally avoid in the third trimester. - Drug interactions: review concomitant NSAIDs, anticoagulants, and ACE inhibitors. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Ibuprofeno Kabi may interact with several drug classes; careful review is essential.

Major Interactions (Avoid): - Other NSAIDs: increased risk of gastrointestinal bleeding. - Anticoagulants (e.g., warfarin): heightened bleeding risk. - ACE inhibitors or ARBs: may impair renal function.

Moderate Interactions (Monitor Closely): - Diuretics: monitor renal function and electrolytes. - SSRIs or SNRIs: observe for signs of bleeding.